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ABSTRACT
Neck ventroflexion in cats has different causes; however, the most
common is the hypokalemia associated with flaccid paralysis
secondary to chronic renal failure. In humans, the most common
causes of acute flaccid paralysis are hypokalemia precipitated by
thyrotoxicosis and familial forms linked to mutations in sodium,
potassium, and calcium channel genes. Here, we describe the
sequencing and analysis of skeletal muscle ion channels in Felis
catus that could be related to periodic paralyses in humans,
contributing to the understanding of the genetic susceptibility to
feline neck ventroflexion and paralysis. We studied genomic DNA
from eleven cats, including five animals that were hyperthyroid with
hypokalemia, although only one presented with muscle weakness,
and six healthy control domestic cats. We identified the ion channel
ortholog genesKCNJ2, KCNJ12, KCNJ14,CACNA1S andSCN4A in
the Felis catus genome, together with several polymorphic variants.
Upon comparative alignment with other genomes, we found that Felis
catus provides evidence for a high genomic conservation of ion
channel sequences. Although we hypothesized that neck
ventroflexion in cats could be associated with a thyrotoxic or
familial periodic paralysis channel mutation, we did not identify any
previously detected human channel mutation in the hyperthyroid cat
presenting hypokalemia. However, based on the small number of
affected cats in this study, we cannot yet rule out this molecular
mechanism. Notwithstanding, hyperthyroidism should still be
considered as a differential diagnosis in hypokalemic feline paralysis.
KEY WORDS: Potassium channel, Inward rectifier, Felis catus,
Kir2.x, KCNJ2, KCNJ12, KCNJ18, CACNA1S, SCN4A, Cat
INTRODUCTION
Ion channels are macromolecular protein complexes that are
components of the cell membrane and are essentially important in
different types of signaling, including transport, excitability, and
conduction. Alterations in these channels may dynamically
disturb cell and tissue physiology (Hille, 2001).
Indeed, there are many diseases related to ion channel
dysfunction. In general, dominant and recessive mutations in genes
encoding channels may lead to electrophysiological dysfunction,
resulting in hyper- or hypo-excitability of the corresponding cells
and typically causing so-called channelopathies (Abraham et al.,
1999; Rolim et al., 2010; Jongsma and Wilders, 2001; Souto, 2011).
Such altered genes can give rise to different clinical manifestations
through gain-of-function (enhance) or loss-of-function (attenuate)
mutations that affect the channel activity. Certain congenital
disturbances affecting the skeletal muscle have been identified in
humans and animals, such as disorders in calcium and potassium
channels that can lead to paralysis and disorders in chloride channels
that can lead myotonia; additionally, both paralysis and myotonia
can originate from sodium and calcium channel disequilibrium.
Hypokalaemic Periodic Paralyses (HypokPP) include several
uncommon diseases with clinical presentation characterized by
acute and reversible attacks of muscle weakness, especially of the
lower extremities, associated with low serum potassium. The most
prevalent causes of HPP are Familial Hypokalaemic Periodic
Paralysis (FHypokPP), an autosomal dominant disease, and an
acquired form Thyrotoxic Hypokalaemic Periodic Paralysis
(THypokPP), secondary to any cause of thyrotoxicosis. The
symptoms of paralysis and the grade of hypokalaemia are almost
identical in both FHypokPP and THypokPP, the differences in
clinical features are related to the signs of thyrotoxicosis present in
THPP (Rolim et al., 2010). Although work in human medicine has
broadened the clinical spectrum by identifying several new channel
mutations, such molecular genetic research on paralysis is seldom
reported in veterinary medicine, and a promising feline animal
model of THypokPP would be attractive for further genetic studies.
Felis catus is an interesting species for the study of human
diseases. There are many instances in which the relationship
between clinical signs, etiological agents, and molecular analysis
of different pathologies has been established in cats (O’Brien
et al., 1997a; O’Brien et al., 1997b), and the possible amino acid
and gene sequence conservation among species throughout
evolution may allow the identification of orthologous and
syntenic genes that share a common evolutionary origin
(Navratilova and Becker, 2009; Nomiyama et al., 2013; Ohno,
1973), therefore this animal model would shed light on the
understanding of similar skeletal muscle diseases between man
and cat.
Indeed, a comparison of genomes and analysis of synteny among
ion channels using PCR, cloning, and sequence alignment would
be useful for the molecular diagnosis of feline channelopathies.
Here, we describe the channel genes KCNJ2, KCNJ12, KCNJ14,
SCN4A, and CACNA1S in Felis catus in an attempt to associate the
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single-nucleotide polymorphisms (SNPs) found in these genes with
feline ventroflexion and muscle paralysis.
RESULTS AND DISCUSSION
We were able to study eleven cats including five hyperthyroid
animals with hypokalemia, with only one presenting with muscle
weakness, and six healthy control domestic cats, as summarized in
Table 2. Since, familial hypokalemic periodic paralysis
(FHypokPP) is an autosomal dominant disease associated with
mutations in calcium channels CACNA1S (Cav1.1) and SCN4A
(Nav1.4) (Kim et al., 2011; Sternberg et al., 1993), and sporadic/
thyrotoxic hypokalemic paralysis is related to mutations in KCNJ18
(Kir2.6) (Cheng et al., 2011; Maciel et al., 2011; Ryan et al., 2010;
Silva et al., 2004; Wang et al., 2006), we approached principally
these genes. The KCNJ18 mutants are primarily associated with
THypokPP, an acquired genetic susceptibility condition in human.
Molecular cloning of fKir2.1, fKir2.2 and fKir2.6 (or the
human-like KCNJ2, KCNJ12 and KCNJ18 genes)
Of the neuromuscular disorders, cervical ventroflexion is a classic
sign of generalized neuromuscular weakness in cats that can have
different causes (Dickinson and LeCouteur, 2004). Cats, particularly
the Burmese and Siamese breeds, exhibit paralysis associated with
hypokalemia and muscle weakness similar to THypokPP in humans
(Table 3) and has been termed hypokalemic periodic polymyopathy
(HypoPP), sporadic feline hypokalemic polymyopathy, or periodic
muscle weakness (Jones and Gruffydd-Jones, 1990; Lantinga et al.,
1998). These conditions appear to be related to a sudden influx of
potassium from the extracellular to intracellular compartment that is
not accompanied by decreased potassium intake or increased renal
potassium loss (Vite, 2002); however, the conditions have never been
related to hyperthyroidism. Curiously, hypokalemia as a metabolic
disease has also been detected in hyperthyroid cats (Crystal and
Norsworthy, 2009; Dickinson and LeCouteur, 2004; Nemzek et al.,
1994), although the potassium depletion in this state was generally
considered secondary to reduced potassium ingestion or increases in
the fractional excretion of potassium in urine (Fettman, 1989). Our
study focusing on genes related to THypokPP in humans and our
interest in identifying orthologous genes raises the hypothesis of
Felis catus being the closest animal model for this skeletal muscle
condition. Accordingly, we parallel THypokPP crisis in humans to
ventroflexion plus paralysis in thyrotoxic hypokalemic cats.
Based on the analysis of eleven domestic cats, we cloned the
genes encoding Kir2.1 (KCNJ2), Kir2.2 (KCNJ12), and Kir2.6
(KCNJ18) from feline genomic DNA using human primers with
low-stringency PCR and sequencing. We found that human
Kir2.6 shares 96–99% amino acid identity with Kir2.2 and human
Kir2.2 shares over 70% identity at the amino acid level with
Kir2.1 (Ryan et al., 2010). We also found that the relationship
between the two genes is preserved in cats and that the sequences
are highly conserved between the species.
PCR amplification using primers designed for hKir2.1 gene yielded
a product of approximately 750 bp when examined on a 1% agarose
gel (Fig. 1A). Its sequence represents the second exon of fKir2.1
(fKCNJ2) gene; this fragment included the feline coding region of the
predicted human-like KCNJ2 harboring 222 amino acids, which was
then construed from the human sequence (GenBank: NG_008798).
Primers designed based on the hKir2.2 gene yielded a product of
approximately 625 bp (Fig. 2A), which sequencing revealed that this
fragment represents the third exon, comprising part of the coding
region of fKir2.2 (fKCNJ12) gene, encoding 195 residues, which was
also inferred to the human sequence (GenBank: NW_003315950.1).
Through the alignment of feline-like KCNJ2 (750 bp) and
KCNJ12 (625 bp) segments in the NCBI Felis catus genome
Table 1. Details of primers used in this study for PCR, cloning and sequencing assays
Gene Exon_primer Sequence MT
KCNJ2 Ex2_F 59-CTGGAGTTCCACAGCAGAAG-39 55.5
Ex2_R 59-GATCACAGCATTGTGACTGAAG-39 53.9
Ex2_F 59-GCTATGGCTTCAGGTGTGTC-39 55.8
Ex2_R 59-TGGGCCTTTGACCAACAGA-39 56.9
KCNJ12/KCNJ18 EX3_F 59-TGCCGTTTTTCTCCATTACAG-39 54.4
Ex3_R 59-CTCCACGATGTGGCTCTTAC-39 55.2
Ex3_F 59-GACGCTGCTGTTCAGTCAC-39 56.4
Ex3_R 59-CGGGGCGGATGCT-39 55.6
KCNJ4 Ex2_F 59-CTCGGGCTTCTCCTCCCCAG-39 60.6
Ex2_R 59-CCTCCAGGTCGCCGTGGAAG-39 61.5
Ex2_F 59-CCCCCAAGCCCTGCATCATG-39 60.8
Ex2_R 59-CAGAGGCGCCTGTGGGAAG-39 61.1
KCNJ14 Ex2_F 59-CGCTGGATGTGCCTGCTCTTC-39 61.5
Ex2_R 59-GAGCTTACGTCTCCCACCATCCG-39 63.1
Ex3_F 59-CCCGCCTCTGTCTTTGGCC-39 61.6
Ex3_R 59-CGGGAAGGGGGTACAAATCGG-39 61.5
SCN4A Ex12_F 59-CTCCCTGAGGCTCTGTGACAC-39 61.5
Ex12_R 59-GGGATCTCTCCTCTGACCCTC-39 61.5
Ex18_F 59-TCTAAGGCCCTGCACCTCC-39 59.5
Ex18_R 59-CCCCCGATCCCTAGCCTACT-39 61.6
Ex22_F 59-TGGAGGCAGAGAAGAGGGACC-39 61.5
Ex22_R 59-GGTTCATAGAGGCTGCCAGAGG-39 61.4
Ex24_F 59-CCTCCTACCCAAGGGCAGTG-39 61.6
Ex24_R 59-CATGAGGGAGCTTTGGGGCTG-39 61.5
CACNA1S Ex11_F 59-GCGGTGGCCAAGGCAAAGTC-39 62.2
Ex11_R 59-CAGACGGTCACCGGTGGAGAC-39 61.9
Ex30_F 59-CCTGTGAGGTGCCACCTCCAG-39 62.3
Ex30_R 59-CGCAGCCTCTCCAGGTACGTG-39 62.2
Abbreviations: F, Forward; R, Reverse; MT, melting temperature
RESEARCH ARTICLE Biology Open (2014) 3, 785–793 doi:10.1242/bio.20148003
786
B
io
lo
g
y
O
p
e
n
databank (http://blast.st-va.ncbi.nlm.nih.gov/Blast.cgi), we were
able to uncover in silico the entire feline-like KCNJ2 and
KCNJ12 genes (supplementary material Figs S1, S2, S3) in the
Felis catus contig (GenBank: AANG02076766.1 and
AANG02055501.1, respectively). Therefore, we designed
specific primers corresponding to ends of both sequences to
clone the full-length segments.
In addition, we compared fKCNJ2 (Kir2.1) with other
orthologues available in the NCBI database, revealing high
conservation (Fig. 1C, Fig. 2C) among the cat Kir2.x family
genes and among species. With regard to fKCNJ12, we observed
five amino acids missing in comparison to human KCNJ12
(Fig. 2D), S400–L404 in human Kir2.2; however, it is unclear
how this loss would affect the channel in cats. Different
polymorphisms were also found among different cats (Table 4).
Although we attempted many strategies to identify the KCNJ18
orthologous gene in the feline genome, we were unable to do so
using DNA from peripheral blood lymphocytes or in silico
prediction.
Inwardly rectifying K+ (Kir) currents were first identified in
skeletal muscle (Hibino et al., 2010; Katz, 1949). Regarded as
essential components for establishing a stable and negative
resting membrane potential in many excitable cell types, these
channel proteins (based on their subunits) act as inward current
rectifiers, showing a greater flow of potassium into rather than out
of the cell (Hugnot et al., 1997; Kaibara et al., 2002; de Boer
et al., 2010); Kir channels regulate electrical excitability,
repolarization of the action potential, and clearance of K+ from
the T-tubule system (Kristensen et al., 2006). The functional
subunits of Kir channels are tetrameric (i.e. four subunits), each
of which has two membrane-spanning domains (M1 and M2), a
flanking pore region (H5) (Hugnot et al., 1997), and cytoplasmic
amino (NH2)- and carboxy (COOH)-terminal domains (Fig. 3B)
(Hugnot et al., 1997; Kaibara et al., 2002).
The Kir channel family is encoded by the KCNJ genes
(Dhamoon and Jalife, 2005) and includes seven subfamilies
(Kir1-7) sharing 40–60% homology within each (de Boer et al.,
2010). Different genetic diseases have been recognized in these
channels: Andersen–Tawil syndrome caused by mutations in
Kir2.1 (encoded by KCNJ2) (Obeyesekere et al., 2011; Plaster
et al., 2001); cardiac cell, neuron, and muscle diseases caused by
mutations in Kir2.2 (encoded by KCNJ12) (Hugnot et al., 1997;
Pru¨ss et al., 2005; de Boer et al., 2010); and susceptibility to
thyrotoxic hypokalemic periodic paralysis (THypokPP) (Ryan
et al., 2010), a clinical condition characterized by reversible
attacks of muscle weakness associated with thyrotoxicosis,
hypokalemia, and hypophosphatemia, caused by mutations in
Kir2.6 (T354M, K366R, Q407X, and R399X) (encoded by
KCNJ18) (Dias Da Silva et al., 2002; Maciel et al., 2011; Rolim
et al., 2010; Ryan et al., 2010).
Sequencing of hotspot regions for mutations causing human
paralysis in the Felis catus genome: the SCN4A and
CACNA1S genes
Familial hyperkalemic periodic paralysis (HYPP) is an autosomal
dominant channelopathy generated by mutations in sodium channel
SCN4A (Nav1.4) (Han and Kim, 2011; Pta´cˇek et al., 1991), similar
to HYPP in horses (Aleman, 2008). Other clinical manifestations of
skeletal muscle identified to date are potassium-aggravated
myotonia (PAM), paramyotonia congenita (PMC), hypokalemic
periodic paralysis/familial hypokalemia periodic paralysis (HypoPP/
FPP), and a form of congenital myasthenic syndrome (CMS).
Using PCR with in silico-predicted feline primers, we were able to
identify and confirm the SCN4A cat gene, specifically in relation to
regions identified in association with several periodic paralysis
mutations, including exons 12 (GenBank: KF267755), 18 (GenBank:
KF267756), 22 (GenBank: KF267757), and 24 (GenBank:
KF267758) (Fig. 4). Although no mutations were found with
regard to divergent amino acid sequences compared to human, two
polymorphisms were found in exons 12 and 24 (Table 4).
By targeting hotspot regions in the human CACNA1S gene
(GenBank: NM_001038605), we investigated the corresponding
Table 2. Epidemiological and physiopathological features of the studied cats diagnosed with goiter
Cat Gender Age (yr) Breed
Potassium T4 fT4
Major symptoms(3.9–5.2 mEq/L) (1–4.5 mg/dL) (0.7–2 ng/dL)
1 Male 14 Domestic shorthair 3.2 – – CD/Goiter
2 Male 14 Siamese 4.2 – 4.8 Goiter
3 Female 16 Siamese 3.85 19.72 – Hyporexia/CRD/Goiter
4 Female 20 Domestic shorthair 3.2 14 – Weakness/Weight loss/Goiter
5 Female 15 Domestic shorthair 4.2 13 – Weight loss/Goiter
Abbreviations: T4, thyroxine; fT4, free thyroxine; CD, cardiac disease; CRD, chronic renal disease
Table 3. Major comparative features of hypokalemic periodic paralysis in felines and thyrotoxic periodic paralysis in humans
Feature HypoPP on hyperthyroidism HypoPP on Burmese syndrome Human THypokPP
Thyrotoxicosis ? ? 3
Hypokalemia 3 3 3
Levels of K+ ,3.2 mmol/L ,3.0 mmol/L 1.5–3.0 mmol/L
Reversible attacks 3 3 3
Sudden attacks 3 3 3
Muscle weakness 3 3 3
Neck ventroflexion 3 3 –
Endocrine channelopathy ? ? T3-excess inducing increased K+ shift
Ion channel mutation ? ? Kir2.6 encoded by KCNJ18
Gender preponderance F/M F/M M
Triggering factors Stress, exercise Stress Strenuous exercise, glucocorticoid administration,
heavy rich meal – carbohydrate, infection
Abbreviations: HypoPP, Hypokalemic periodic paralysis; THypokPP, Thyrotoxic hypokalemic periodic paralysis; F, female; M, Male; K+, potassium
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exons 11 and 30 in the cat genome, identifying polymorphisms in
exon 11, as depicted in Table 4 and Fig. 5.
As both CACNA1S (Cav1.1) and SCN4A (Nav1.4) are related
to HypoPP/FPP, autosomal dominant disorders causing either
muscle weakness or flaccid paralysis with incomplete penetrance
and occurring more frequently in young males, with later onset
observed in affected females (Lin et al., 2005), we searched for
mutations in our group of cats affected with muscle weakness.
Although mutations typically affect segment S4 of domains II,
III, and IV of CACNA1S and domains I, II, and III of SCN4A (Lin
et al., 2010), no mutations in these genes (Table 5) were found in
felines.
Channel genes KCNJ2, KCNJ12, SCN4A and CACN1AS
appear to be in synteny
Using NCBI tools (http://www.ncbi.nlm.nih.gov/projects/mapview),
we were able to draw evolutionary genomic relationships (Fig. 6), as
revealed by conservation in sequence identity (.85%), as colinearity
by examining the chromosomal locations. The gene group comprising
KCNJ12, SCN4A, andKCNJ2 is located on chromosome 17 in humans
and chimpanzees, chromosome 11 in mice, and chromosome E1 in
cats; the CACNA1S gene is collinearly positioned on chromosome 1 in
mice, chimpanzees, and humans and on chromosome F1 in cats.
According to O’Brien et al., the syntenic block of feline chromosome
E1 corresponds to human chromosome 17 and most likely murine
chromosome 11 (O’Brien et al., 1997a); thereby it human 1
chromosome corresponds to C1 feline chromosome, which was
reported by Pontius et al. (Pontius et al., 2007).
Our data reinforce the evolutionary structural genomic
relationships among channel ortholog genes, which can suggest
evolutionary gene duplication and further specialization of channel
functioning. With respect to the KCNJ18 gene (Kir2.6), we did not
found this gene in either the genome of Felis catus or the Mus
musculus C2C12 cell line; thus, we hypothesize that it might also
be missing in the other lower mammal species. In fact, we were
able to identify in silico Kir2.6 amino acid similarities in the
predicted chimpanzee trace genome. Regardless, further studies
need to be performed to confirm these findings because of the
difficulty in distinguishing between Kir2.6 from Kir2.2 because
they share high (98%) genomic homology, thereby limiting the
ability to isolate them using ordinary sequencing methods.
Comparative genetic analysis has a high value for evolutionary,
biological, and clinical aspects and allows the establishment of
animal models for understanding interspecies diseases and
Fig. 1. Identification of the KCNJ2 (Kir2.1) gene in Felis catus.
(A) Representative gel electrophoresis of the KCNJ2 PCR product using the
cat and human genomes. (B) Chromatogram of the region surrounding
glycine 206 used for the comparative analysis (C) against other orthologous
genomes available. Note that fKCNJ2 shows 91.1% identity with Homo
sapiens (Hs), 90.6% with Canis familiaris (McFarland et al., 1980), 93% with
Pan troglodytes (Pt), 91.6% with Bos taurus (Sternberg et al., 1993), 87%
with Mus musculus (Pru¨ss et al., 2005), 87.7% with Rattus norvegicus (Rn),
and 84.6% with Gallus gallus (Pta´cˇek et al., 1991). Abbreviations: (M) 1-kb
molecular marker; cat (C) and human (H) PCR products.
Fig. 2. Identification of the KCNJ12 (Kir2.2) gene in
Felis catus. (A) Representative gel electrophoresis of the
KCNJ12 PCR product using the cat and human
genomes. (B) Chromatogram of the region surrounding
glutamine 424 used for comparative analysis (C) against
other orthologous genomes available. Note that fKCNJ12
shows 90% identity with Homo sapiens (Hs), 93% with
Canis familiaris (McFarland et al., 1980), 90% with Pan
troglodytes (Pt), 89% with Bos taurus (Sternberg et al.,
1993), 86% with Mus musculus (Pru¨ss et al., 2005), 85%
with Rattus norvegicus (Rn), and 78% with Gallus gallus
(Pta´cˇek et al., 1991). (D) Five amino acids lacking in the
cat sequence (red line); NM_021012 (human sequence)
and JX484837 (cat sequence). Abbreviations: (M) 1-kb
molecular marker; cat (C) and human (H) PCR products.
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Table 4. Genotype distribution of polymorphic variants found in KCNJ2, KCNJ12, SCN4A and CACN1AS in the group of
hyperthyroid cats and control population
Gene Polymorphism Cat Chromosome Genotype Allele
KCNJ2 C.A Ser (S) 342 Ser (S) CC CA AA C A
C 12 8 2 2 0.75 0.25
HWM 8 6 2 0.75 0.25
HM 2 2 1
A.C Ser (S) 373 Ser (S) AA AC CC A C
C 12 2 6 4 0.4 0.6
HWM 8 2 6 0.13 0.87
HM 2 2 0.5 0.5
T.C Ser (S) 413 Ser (S) TT TC CC T C
C 12 6 6 0.25 0.75
HWM 8 8 1
HM 2 2 1
KCNJ12 C.T Arg (R) 149 Arg (R) CC CT TT C T
C 12 2 4 6 0.33 0.67
HWM 8 4 4 0.5 0.5
HM 2 2 0.5 0.5
CACNA1S_Ex11 C.A Arg (R) 469 Arg (R) CC CA AA C A
C 8 2
HWM 8 4 4 0.5 0.5
HM 2 2 1
SCN4A_Ex12 C.G Pro(P) 628 Pro (P) CC CG GG C G
C 12 10 2 0.92 0.08
HWM 8 8 1
HM 2 2 1
SCN4A_Ex24 C.T Leu(L) 1491 Leu(L) CC CT TT C T
C 12 6 6 0.75 0.25
HWM 8 6 2 0.88 0.12
HM 2 2 0.5 0.5
Abbreviations: C, control; HWM, hyperthyroidism without muscle weakness; HM, hyperthyroidism with muscle weakness.
Fig. 3. Schematic representation of the protein sequence alignment between Felis catus Kir2.1 and Kir2.2. (A) Comparative among human and fKCNJ12
and fKCNJ2 genes. We can observe 91% and 94% of homology in coding region among species. (B) General scheme of the Kir channel subunits. (C) Putative
sequences shared are in bold, showing conserved sequence between subfamily members.
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explaining phenotype–genotype relationships. Although we did
not discover any polymorphisms with clinical or causal
relationships with paralysis/hypokalemia in the cat in this
study, the DNA sequences of these genes are available for
future studies. In the future, we hope to contribute more genetic
studies on the diseases of Homo sapiens/Felis catus.
MATERIALS AND METHODS
Feline peripheral blood genomic DNA extraction
This study was conducted following the guidelines for Ethics Committee of
the University Federal of Sa˜o Paulo registered under CEP 1402/11. We
enrolled 11 cats presented to Clinical Veterinary of Small Animal in Sa˜o
Paulo. DNA extraction was performed using a salting-out procedure according
to an in-house method, as reported by Kizys et al. (Kizys et al., 2012).
Felis catus PCR amplification using in silico predicted
oligonucleotides
We initially used human primers previously designed for human potassium
channel genes to pull out cat genomic sequence by using low-stringency PCR
amplification since their sequence were unknown. The amplifications were
performed using 100 ng feline genomic DNA in a 50-ml reaction containing
90% Platinum PCR SuperMix (Invitrogen, Carlsbad, CA). The reaction was as
follows: an initial denaturation at 94 C˚ for min, followed by 38 cycles of 94 C˚
for 20 sec, 56 C˚ annealing for 30 sec, and 72 C˚ elongation for 1 min, and a
final extension at 72 C˚ for 5 min. For the PCR amplification of the feline
SCN4A and CACNA1S genes, primers were designed in silico using NCBI
human sequences, as shown in Table 1. These predicted primers were used in
a 25-ml PCR reaction containing 100 ng/ml genomic DNA (1 ml) and 22.5 ml
PlatinumH PCR SuperMix (Invitrogen, Carlsbad, CA, USA); the reaction
consisted of 35 cycles at 94 C˚ for 5 min, followed by 94 C˚ for 30 sec, 60 C˚
for 45 sec, and a final extension at 72 C˚ for 10 min. We applied different
annealing temperatures for specific exons, as detailed in Table 1.
Molecular cloning and sequence analysis of feline ion channels
The expected PCR bands were examined on a 1% agarose gel and then
purified. The purified PCR product was cloned into pCR4HTOPO
(Invitrogen Carlsbad, CA) and transformed into One ShotH MAX
EfficiencyH DH5aTM-T1R Competent Cells (Invitrogen, Carlsbad, CA).
Positive clones were confirmed by sequencing using an ABI Prism 3100
Applied Biosystems Sequencer (CA, USA). The sequences were
analyzed using BioEdit Sequence Alignment Editor and CLC Main
Workbench 6 (http://www.clcbio.com).
List of symbols and abbreviations used
PCR: polymerase chain reaction; SNPs: single-nucleotide polymorphisms;
FHypokPP: familial hypokalemic periodic paralysis; ThyroKPP: thyrotoxic
Fig. 5. Identification of the CACNA1S gene in Felis
catus. (A) Representative gel electrophoresis of the
CACNA1S PCR product using the cat genome.
(B,C) Chromatograms representative of exons 11 and 30,
respectively. Comparison with other available
orthologous genomes. Exon 11: Homo sapiens
(Hs_86%); Canis lupus familiaris (Cf_92%); Pan
troglodytes (Pn_88%); Bos taurus (Bt_92%); Mus
musculus (Mm_88%); Rattus norvegicus (Rn_91%); and
Gallus gallus (Gg_81%). Exon 30: 100% with Homo
sapiens, Canis lupus familiaris, Pan troglodytes, and
Rattus norvegicus; Mus musculus (Mm_95%); and
Gallus gallus (Gg_81%).
Fig. 4. Identification of the SCN4A gene in Felis
catus. (A) Representative gel electrophoresis of the
SCN4A PCR product using the cat genome. We obtained
products about for exon 12 (300 bp); exons 18 and 22
(200 bp); exon 24 (1.3 kb). (B–E) Chromatograms
representative of exons 12, 18, 22, and 24, respectively.
Comparison with other available orthologous genomes.
Exon 12: Homo sapiens (Hs_97%), Rattus norvegicus
(Rn_95%), Mus musculus (Mm_95%), Gallus gallus
(Gg_98%), Canis lupus familiaris (Cf_97%), Pan
troglodytes (Pn_97%), and Bos taurus (Bt_97%). Exon
18: 100% with Homo sapiens, Rattus norvegicus, Mus
musculus, Canis lupus familiaris, and Bos taurus; Gallus
gallus (Gg_93%); and Pan troglodytes (Pn_96%). Exon
22: Homo sapiens (Hs_97%); 100% with Rattus
norvegicus, Mus musculus, Gallus gallus, Canis lupus
familiaris, Pan troglodytes, and Bos taurus. Exon 24:
Homo sapiens (Hs_94%); Rattus norvegicus (Rn_89%);
Mus musculus (Mm_89%); Gallus gallus (Gg_85%);
Canis lupus familiaris (Cf_98%); Pan troglodytes
(Pn_94%); and Bos taurus (Bt_93%). Abbreviations:
(Ex12) exon 12, (Ex18) exon 18, (Ex22) exon 22, and
(Ex24) exon 24.
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periodic paralysis; HypoPP: hypokalemic periodic polymyopathy; HYPP:
familial hyperkalemic periodic paralysis; PAM: potassium-aggravated
myotonia; PMC: paramyotonia congenital; HypoPP/FPP: hypokalemic
periodic paralysis/familial hypokalemia periodic paralysis; CMS: congenital
myasthenic syndrome; CEP: Ethics Committee of the University Federal of
Sa˜o Paulo; C: control; HWM: hyperthyroidism without muscle weakness;
HM: hyperthyroidism with muscle weakness; CD: cardiac disease; CRD:
chronic renal disease; F: forward; R: reverse; MT: melting temperature.
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